mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

ADHD and Nicotine Use in Schizophrenia and Asperger Syndrome: A Controlled Study

Hallerback MU et al. – The prevalence of comorbid ADHD was high in schizophrenia and Asperger syndrome. The Wender–Reimherr Adult Attention Deficit Diagnostic Rating Scale self–rating scale for ADHD can be one useful tool for assessing comorbid ADHD in these patient groups.

Methods
  • Ninety-five individuals, 41 with schizophrenia and 54 with Asperger syndrome, were included.
  • Self-rating of adult ADHD symptoms with the Wender–Reimherr Adult Attention Deficit Diagnostic Rating Scale (WRAADDS), parent rating of proband’s ADHD childhood and adult life symptoms using the Swanson, Nolan, and Pelham Questionnaire (SNAP), and report of clinical ADHD diagnosis were included as ADHD measures.
  • Nicotine use data were compared with data from a population sample.

Results
  • In all, 10% of the schizophrenia group and 30% of the Asperger syndrome group had a clinical ADHD diagnosis.
  • Nicotine dependency in the whole sample was closely linked to ADHD.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close